Skip to main content

Gain-of-Function Research: A Symposium

Completed

Potential Risks and Benefits of Gain-of-Function Research is the summary of a two-day public symposium on Gain of Function (GOF) research. Convened in December 2014 by the National Research Council and the Institute of Medicine, the main focus was to discuss principles important for, and key considerations in, the design of risk and benefit assessments of GOF research. Participants examined the underlying scientific and technical questions that are the source of current discussion and debate over GOF research involving pathogens with pandemic potential. This report is a record of the presentations and discussion of the meeting.

Description

An ad hoc committee established by the National Research Council will organize two public symposia. The first symposium, which will be held early in the U.S. government deliberative process on selected GOF research, will examine the underlying scientific and technical questions that are the source of current discussion and debate over GOF research involving pathogens with pandemic potential. The topics to be addressed include:

o Potential benefits of the research, including whether, in addition to generating new scientific knowledge about organisms, it will:

  • Inform public health responses to a potential pandemic, in particular by supporting surveillance efforts to identify possible pandemic strains and provide more time for preparedness; and
  • Facilitate the development of vaccines and antiviral therapeutics.

o Potential risks associated with the research, in particular those related to biosafety and biosecurity.
o Alternative methods that may be employed to yield similar scientific insights and/or potential benefits, while reducing potential risks.

The public symposium will not result in the development of consensus recommendations, but rather will elicit individual perspectives and robust discussion on the topics described above. The committee will develop the symposium agenda, select and invite speakers and discussants, and moderate the discussions. Invited participants will have a diverse range of perspectives and expertise, including but not limited to public health, biosafety, public health surveillance, research, security, drug and vaccine development, and should also include experts from regions of the world where pathogens with pandemic potential are endemic and from regions of the world conducting GOF research on such pathogens. The two-day symposium will be webcast and the presentations and background materials will be archived online. An individually authored brief workshop summary of the presentations and discussions at the symposium will be prepared by a designated rapporteur in accordance with institutional guidelines.

Collaborators

Sponsors

Alfred P. Sloan Foundation

Internal Funding

John D. and Catherine T. MacArthur Foundation

National Institutes of Health

Wellcome Trust

Staff

Fran Sharples

Lead

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.